ACADIA Pharmaceuticals Stock Price. Everything You Need To Know About The ACADIA Pharmaceuticals Stock!
Acadia Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops and commercializes novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The Company’s pipeline product candidates in CNS areas includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. The Company has initiated a Phase II study evaluating ACP-044 for the treatment of postoperative pain following bunionectomy surgery. The Company also initiated an additional Phase II study evaluating ACP-044 for the treatment of pain associated with osteoarthritis. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).
ACADIA Pharmaceuticals Stock Price. Everything You Need To Know About The ACADIA Pharmaceuticals Stock! performance
- Employees 511
- Company HQ San Diego
- Website https://acadia.com/
- ACAD Asset Type Common Stock
- ACAD Market Capitalization 2.8B
- Earnings Per Share -0.37
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you looking to invest in ACADIA Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam? Look no further, as Zorion, the leading investment platform, is here to guide you. ACADIA Pharmaceuticals is a renowned company in the biopharmaceutical sector, specializing in the development and commercialization of innovative medicines to address unmet medical needs. By investing in ACADIA Pharmaceuticals, you become part of a growing industry that aims to improve the lives of patients worldwide. Our platform offers investment insights, recommendations, and educational resources to help you make informed decisions. Start investing in ACADIA Pharmaceuticals today and embark on a journey towards financial growth and success.
